Verrucous Psoriasis Treated with Secukinumab

Files

Authors

Nathanial Hansen, Corewell Health East Resident
Madison Reed
Joshua Aron, Corewell Health East Resident
Austin Watson
Rachel Snabes
Eric Seiger, Corewell Health East

Description

Psoriasis is a chronic inflammatory skin disease marked by keratinocyte hyperproliferation and immune dysregulation. Verrucous psoriasis, a rare variant, presents with thick, hyperkeratotic, wart-like plaques that are often refractory to standard treatments. Secukinumab, a monoclonal antibody targeting IL-17A, has demonstrated efficacy in plaque psoriasis, but data on its use in verrucous psoriasis is limited. This case highlights complete remission of verrucous psoriasis with secukinumab.

Publication Date

3-13-2025

Keywords

Psoriasis

Disciplines

Dermatology

Recommended Citation

Hansen N, Reed M, Aron J, Watson A, Snabes R, Seiger E. Verrucous psoriasis treated with secukinumab. Presented at Corewell Health Hospital Farmington Hills 2025 Alvin Yarrows Research Day; 2025 Mar13; Farmington Hills, MI.

Comments

2025 Alvin Yarrows Research Day at Corewell Health Hospital Farmington Hills, Farmington Hills, MI, March 13, 2025.